Skip to main content

Table 5 clinical characteristics of PMN patients who detected circulating anti-PLA2R antibodies

From: The association between variants in PLA2R and HLA-DQA1 and renal outcomes in patients with primary membranous nephropathy in Western China

Characteristic anti-PLA2R ( +) anti-PLA2R (-) P
Baseline n = 91 n = 29
Age at biopsy (years) 51.07 ± 12.66 48.0 ± 15.63 0.172
Male (n, %) 57 (62.2) 15 (51.7) 0.296
Cr (μmol/L) 73.17 ± 25.05 75.60 ± 52.47 0.736
eGFR (ml/min/1.73 m2) 95.77 ± 21.78 100.84 ± 27.78 0.311
Urea (mmol/L) 6.17 ± 4.32 5.55 ± 2.71 0.472
Alb (g/L) 27.97 ± 26.29 27.7 ± 7.64 0.959
24 h-u-pro (g/d) 5.08 ± 3.55 4.36 ± 5.75 0.436
SBP (mmHg) 131.96 ± 15.16 127.89 ± 15.77 0.222
DBP (mmHg) 79.55 ± 10.68 78.39 ± 10.22 0.614